Close
Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort Jun 1, 2024 01:02PM
  • In 17 EGFR wild-type (EGFRwt) non-small cell lung cancer (NSCLC) patients who failed chemotherapy and PD-1/PD-L1, AFM24 plus atezolizumab achieved 4 objective responses; 3 of 4 responses were ongoing for more than 7 months and progression free survival (PFS) was 5.9 months
  • Objective responses were also seen in 4 of 13 response-evaluable EGFR mutant (EGFRmut) NSCLC patients confirming the activity of AFM24 and atezolizumab in heavily pretreated NSCLC patients
  • In both NSCLC... (continue reading...)

PHILADELPHIA KICKS OFF PRIDE MONTH BY SETTING THE FIRST-EVER GUINNESS WORLD RECORDS™ FOR THE "LARGEST ATTENDANCE AT DRAG QUEEN STORY TIME" Jun 1, 2024 01:01PM

Famed Drag Performers and 263 Attendees Gathered on Philadelphia's Iconic Independence Mall to Make History

PHILADELPHIA, June 1, 2024 /PRNewswire/ -- Philadelphia, the birthplace of America, today secured a new GUINNESS WORLD RECORDS title for the "largest attendance at a drag queen story time reading." To kick off Pride Month, the Philadelphia Gay News hosted the event, sponsored by Visit Philadelphia®, which brought together famed Philadelphia drag performers to... (continue reading...)


Union members and allies mark Injured Workers’ Day in locations across Ontario Jun 1, 2024 12:55PM

TORONTO, June 01, 2024 (GLOBE NEWSWIRE) -- The Ontario Federation of Labour (OFL) was pleased to support several events across Ontario today, as injured workers and their allies marked Injured Workers’ Day in the province.

“For decades, injured workers have been leading the fight for justice for workers injured on the job,” said Laura Walton, OFL President. “We echo their call for a comprehensive compensation system that covers all workers and real income... (continue reading...)


FameEX CEO’s Message: Keep the Intention in the Crypto Bull Market for a Better Departure Jun 1, 2024 12:30PM

FameEX CEO’s Message: Keep the Intention in the Crypto Bull Market for a Better Departure

The cryptocurrency market has surged following the U.S. SEC's approval of the Bitcoin Spot ETF application from 11 major financial institutions. This landmark decision has legitimized cryptocurrency investments, attracting significant capital from traditional financial sectors. The influx of institutional funds, coupled with global... (continue reading...)


Prospera Energy Inc. Announces 2023 Financial Results Jun 1, 2024 12:36PM

CALGARY, Alberta, June 01, 2024 (GLOBE NEWSWIRE) -- Prospera Energy Inc. ("Prospera" or the "Corporation") (PEI: TSX-V; OF6A: FRA)

2023 was a transformational year for Prospera transforming to horizontal well technology in the Saskatchewan heavy-oil fields. Also, to initiate medium/light-oil development to diversify from predominately a heavy oil producer. The company successfully drilled, completed, and tied in 9 horizontal wells in its Saskatchewan heavy-oil fields... (continue reading...)


More Press Releases

View Older Stories

Jun 1, 2024 11:40AM Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling!
Jun 1, 2024 11:00AM WATCH by Aisles: A Revolutionary AI System for Public Safety
Jun 1, 2024 11:56AM CIO Women Magazine Spotlights Claudia Patricia Eusse, CEO, The Eusse Group, as Influential Women Leaders in Real Estate
Jun 1, 2024 11:56AM Mr. Business Magazine Spotlights Diana Muniz-Lebrun, Founding Partner and CEO at Olympus Marketing
Jun 1, 2024 11:00AM ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
Jun 1, 2024 10:00AM SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical
Jun 1, 2024 10:00AM Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple
Jun 1, 2024 10:00AM First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024
Jun 1, 2024 10:00AM "Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
Jun 1, 2024 10:00AM Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 1, 2024 10:00AM Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-sma
Jun 1, 2024 10:33AM Gregory P Lee Personal Injury Lawyer The Woodlands Expands Services to Meet Rising Demand in Texas for Personal Injury Cases
Jun 1, 2024 10:30AM Innovative Solutions and Cutting-Edge Technologies Take Centre Stage at Water Expo Delhi 2024
Jun 1, 2024 10:28AM Revolutionizing Sustainability: The Environment Protection Technologies Expo
Jun 1, 2024 09:30AM Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
Jun 1, 2024 09:15AM Postmedia Announces Closing of Previously Announced Transaction with the Klein Group
Jun 1, 2024 09:14AM Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
Jun 1, 2024 09:00AM Fungies Mushroom Gummies Announces Major Retail Expansion and Availability at Walmart
Jun 1, 2024 09:00AM Vincent Todd Announces the Introduction of Todd Agriscience
Jun 1, 2024 09:00AM Hyundai Motor America Reports May 2024 Sales
Jun 1, 2024 09:00AM Beverly Hills MD Celebrates Its 10th Anniversary
Jun 1, 2024 09:00AM American Cancer Society and American Society of Clinical Oncology Unite to Create One of the Largest and Most Comprehensive Online Sources of Credible Cancer Information
Jun 1, 2024 09:00AM Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
Jun 1, 2024 09:00AM Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community
Jun 1, 2024 09:00AM Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
Jun 1, 2024 09:00AM ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
Jun 1, 2024 09:18AM 5 Ways BPO Services Can Improve Your Business Operations
Jun 1, 2024 09:18AM Amazed by these incredible facts about the yellow diamond
Jun 1, 2024 09:18AM Maximizing Efficiency: The Role of Content Moderation Services
Jun 1, 2024 09:18AM Wisconsin Top Performing Stocks
Jun 1, 2024 08:15AM FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 1, 2024 08:15AM Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 1, 2024 08:15AM Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
Jun 1, 2024 08:10AM Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual
Jun 1, 2024 08:05AM Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
Jun 1, 2024 08:05AM Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
Jun 1, 2024 08:00AM Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Jun 1, 2024 08:00AM Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse
Jun 1, 2024 08:00AM James Avery Artisan Jewelry Opens New Store at Westover Marketplace
Jun 1, 2024 08:00AM Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
Jun 1, 2024 08:00AM TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting
Jun 1, 2024 08:00AM Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
Jun 1, 2024 08:00AM Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Jun 1, 2024 08:00AM Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
Jun 1, 2024 08:00AM BALEAF & SOJOS to host "Summer it up" summer fashion extravaganza!
Jun 1, 2024 08:00AM Boehringer Ingelheim's COPD and asthma inhalers are now available for $35 a month for eligible patients
Jun 1, 2024 08:00AM KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Canc
Jun 1, 2024 08:00AM Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
Jun 1, 2024 08:00AM OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform
Jun 1, 2024 08:00AM Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
View Older Stories